Abstract: The invention provides compounds of the formula I
wherein the substitutents are as described herein.
Further provided are methods of using such compounds for the treatment of nuclear hormone receptor-associated conditions, such as age related diseases, for example sarcopenia, and also provided are pharmaceutical compositions containing such compounds.
Type:
Grant
Filed:
July 31, 2002
Date of Patent:
December 30, 2003
Assignee:
Bristol-Myers Squibb Company
Inventors:
Chongqing Sun, Jeffrey A. Robl, Mark E. Salvati, Tammy Wang, Lawrence Hamann, David Augeri
Abstract: The present application describes modulators of CCR3 of formula (I):
or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases.
Type:
Grant
Filed:
October 23, 2001
Date of Patent:
February 18, 2003
Assignee:
Bristol-Myers Squibb Pharma Co.
Inventors:
Soo S. Ko, George V. DeLucca, John V. Duncia, Joseph B. Santella, III, Daniel S. Gardner
Abstract: The invention comprises an electrical connector assembly having a wire housing with a wire contact disposed therein. The wire contact has two ends, one of the ends having insulation displacing slots for receiving a magnet wire therein, the other of the ends having a resilient contact finger. The assembly further includes a connector housing having a tab contact disposed therein. The tab contact has a poke-in tab and a contact tab for mating with a matable connector. The wire housing is matable with the connector housing, the poke-in tab engages the resilient contact finger to provide electrical connection therebetween and to provide electrical connection between the magnet wire and the matable connector.
Type:
Grant
Filed:
May 23, 1996
Date of Patent:
July 21, 1998
Assignee:
The Whitaker Corporation
Inventors:
Michael Scott Feher, Edward John Howard, Nelson Edward Neff
© 2024 Justia
